Latest News
Friday November 14, 2008 — PR Newswire
LAVAL, QC, Nov. 13 /CNW/ -- LAVAL, QC, Nov. 13 /CNW/ - BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced its financial and operational results for the second quarter of fiscal 2009, ended September 30, 2008."We cont...
Saturday October 18, 2008 — PR Newswire
LAVAL, QC, Oct. 17 /CNW/ -- LAVAL, QC, Oct. 17 /CNW/ - BioSyntech, Inc. (TSX: BSY) (the Company) announced today that Mr. Claude LeDuc has tendered his resignation, effective December 31, 2008, as CEO of the Company to pursue other interests. He also resigned immediately as a member of the Board. ...
Friday September 12, 2008 — PR Newswire
TORONTO, Sept. 11 /CNW/ -- TORONTO, Sept. 11 /CNW/ - DELISTING REVIEW - BioSyntech, Inc. (the "Company") - Further to TSX Bulletin 2008-0653 dated June 17, 2008, TSX has completed its review of the common shares of the Company (Symbol: BSY) and has determined that it meets TSX's continued listing ...
Tuesday July 29, 2008 — Zacks.com: Analyst Blog
We are maintaining a Hold recommendation on British Sky Broadcasting Group, better known as BSkyB (BSY) prior to the Q4 results due on July 30. The recent UK Competition report is likely to be unfavorable to BSY as it recommended that BSY cut its stake in the country's largest commercial ...
Friday July 18, 2008 — PR Newswire
LAVAL, QC, July 18 /CNW/ -- /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOTINTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES ORDISSEMINATION IN THE UNITED STATES/LAVAL, QC, July 18 /CNW/ - BioSyntech, Inc. (the "Company") (TSX:BSY) is pleased to announce that a...
Tuesday July 15, 2008 — PR Newswire
LAVAL, QC, July 15 /CNW/ -- /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOTINTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES ORDISSEMINATION IN THE UNITED STATES/LAVAL, QC, July 15 /CNW/ - BioSyntech, Inc. (the "Corporation") (TSX:BSY) is pleased to announce th...
Tuesday July 8, 2008 — PR Newswire
LAVAL, QC, July 8 /CNW/ -- /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOTINTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES ORDISSEMINATION IN THE UNITED STATES/LAVAL, QC, July 8 /CNW/ - BioSyntech, Inc. (the "Corporation") (TSX: BSY) announced today that it ha...
Saturday June 28, 2008 — PR Newswire
LAVAL, QC, June 27 /CNW/ -- /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOTINTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES ORDISSEMINATION IN THE UNITED STATES/LAVAL, QC, June 27 /CNW/ - BioSyntech, Inc. ("BioSyntech" or the "Company") (TSX: BSY), a biotechno...
Wednesday June 18, 2008 — PR Newswire
LAVAL, QC, June 18 /CNW/ -- /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOTINTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES ORDISSEMINATION IN THE UNITED STATES./LAVAL, QC, June 18 /CNW/ - On June 17, 2008, the Toronto Stock Exchange (the "TSX") announced that...
Wednesday June 18, 2008 — PR Newswire
TORONTO, June 17 /CNW/ -- TORONTO, June 17 /CNW/ - TSX is reviewing the common shares of BioSyntech, Inc. (Symbol: BSY) with respect to meeting the continued listing requirements. The company has been granted 90-days in which to regain compliance with these requirements, pursuant to the Remedial R...
Tuesday June 17, 2008 — PR Newswire
TORONTO, June 17 /CNW/ -- TORONTO, June 17 /CNW/ - Trading resumes in:Issuer Name: BioSyntech Inc.TSX Ticker Symbol: BSYResumption Time: Opening Tuesday, June 17th, 2008
Thursday April 24, 2008 — PR Newswire
LAVAL, QC, April 24 /CNW/ -- LAVAL, QC, April 24 /CNW/ - BioSyntech, Inc. ("BioSyntech" or "the Company") (TSX: BSY), a biotechnology company developing novel products in regenerative medicine, today announced that its abstract summarizing the safety and effectiveness of BST-DermOn(TM) in promotin...
Monday April 7, 2008 — PR Newswire
LAVAL, QC, April 7 /CNW/ -- LAVAL, QC, April 7 /CNW/ - BioSyntech, Inc. ("BioSyntech" or "the Company") (TSX: BSY), a biotechnology company developing novel products in regenerative medicine, today announced that it has achieved international certification under the stringent and globally recogniz...
Monday March 17, 2008 — PR Newswire
LAVAL, QC, March 17 /CNW/ -- LAVAL, QC, March 17 /CNW/ - BioSyntech, Inc. ("BioSyntech" or "the Company") (TSX: BSY), a biotechnology company developing novel products in regenerative medicine, today announced it has received positive preliminary results from a prospectively planned six-month inte...
Wednesday March 5, 2008 — PR Newswire
LAVAL, QC, March 4 /CNW/ -- LAVAL, QC, March 4 /CNW/ - BioSyntech, Inc. ("BioSyntech" or "the Company") (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced that five abstracts have been selected for presentation as posters at the 54th...
Thursday February 14, 2008 — PR Newswire
LAVAL, QC, Feb. 13 /CNW/ -- LAVAL, QC, Feb. 13 /CNW/ - BioSyntech, Inc. ("BioSyntech" or "the Company") (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced its financial results for the three and nine-month periods ended December 31, ...
Saturday November 24, 2007 — Zacks.com: Analyst Blog
A Hold recommendation has been issued to media giant British Sky Broadcasting Group (BSY), by Zacks senior media analyst Duong Vuong, CFA. Here's what his latest update had to say:'We are initiating coverage of BSY with a Hold recommendation. The first quarter results saw a 28% drop in pr...